Reply to Bouva et al. Comment on "Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. Int. J. Neonatal Screen. 2023, 9, 66"
Int J Neonatal Screen. 2024 Sep 24;10(4):66.
doi: 10.3390/ijns10040066.
1 Section of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
2 Laboratory of Metabolic Diseases, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
3 Section of Pediatric Gastroenterology and Hepatology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
4 Department of Genetics, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
5 Princess Máxima Center for Pediatric Oncology, 3584 CX Utrecht, The Netherlands.
6 Department of Pediatric Infectious Disease and Immunology, Amalia's Children Hospital, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
7 Section Metabolic Diseases, Department of Pediatrics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.